Autres langues Pharma Mar, S.A.

Actions

PHM

ES0169501022

Marché Fermé - BME Autres places de cotation 17:35:26 26/04/2024			Varia. 5j.	Varia. 1 janv.
28,96 ^EUR	+0,49%		+10,37%	-29,50%

23/04	Pharma Mar, S.A. présente ses résultats pour le premier trimestre clos le 31 mars 2024	CI
29/02	Transcript : Pharma Mar, S.A., 2023 Earnings Call, Feb 29, 2024

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

EN DIRECTO DESDE LOS MERCADOS: Iberdrola, Inditex, BBVA, Pharma Mar, Vocento, Acerinox, Air Liquide, Kering, Tesla, Heineken, ENI...	24/04
Pharma Mar, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	23/04
EN DIRECTO DESDE LOS MERCADOS: Naturgy, Viscofan, Endesa, Bankinter, Aena, BYD, TotalEnergies, Tesla, UBS, Salesforce, Nike...	22/04
IN DIRETTA DAI MERCATI: Generali, Viscofan, Telecom Italia, Iveco, Henkel, BYD, TotalEnergies, Tesla, UBS, Salesforce, Nike...	22/04
Pharma Mar, S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	28/02
OPINIONES DE LOS ANALISTAS DEL DÍA : Adyen, Endesa, Viscofan, Iberdrola, Repsol, Pharma Mar, NH Hotel, Nemetschek, Société Générale...	09/02
Bolsa de Madrid: Caramba, ¡falló otra vez!	09/02
PharmaMar presents new results of lurbinectedin at the ASCO Symposium on Genitourinary Cancers	30/01
EN DIRECTO DESDE LOS MERCADOS: Pharma Mar, Repsol, Cie Automotive, Alphabet, UBS, Acciona, Richemont, Covestro, Apple...	19/12
Pharma Mar's Sylentis Meets Primary Endpoint for Dry Eye Disease Medication	18/12
Pharma Mar Partner Wins Marketing Approval for Lung Cancer Drug in Hong Kong	12/12
PharmaMar receives approval of Zepzelca for the treatment of metastatic small cell lung cancer in Macau, China	05/12
Pharma Mar Partner Wins Approval for Lung Cancer Drug in Macao	04/12
Pharma Mar's Partner Wins Commercialization Approval for Zepzelca in Peru	07/11
PharmaMar receives a payment of 10 million dollars from Janssen as a commercial milestone	07/11
PharmaMar Gets $10 Million Milestone Payment from Janssen Under Yondelis Licensing Deal	06/11
EN DIRECTO DESDE LOS MERCADOS: Pharma Mar, Sacyr, LVMH, Iberdrola, Dufry, Berkshire Hathaway, Ryanair, Telecom Italia	06/11
Pharma Mar, S.A. Reports Earnings Results for the Nine Months Ended September 30, 2023	26/10/23
PharmaMar presents new data on lurbinectedin for small cell lung cancer at ESMO 2023	19/10/23
OPINIONES DE LOS ANALISTAS DEL DÍA : Amadeus, Sacyr, Nokia, Telefónica, Pharma Mar, Novo Nordisk, Rheinmetall, Prosegur, Almirall, Vodafone...	11/10/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Pharma Mar, S.A.

Actions

PHM

ES0169501022

Autres langues

Filtres